Tag Archives: Lastest

Home

Lastest Albinism auctions

Published by:

Albinism eBay auctions you should keep an eye on:

[wprebay kw=”albinism” num=”12″ ebcat=”-1″]
[wprebay kw=”albinism” num=”13″ ebcat=”-1″]
[wprebay kw=”albinism” num=”14″ ebcat=”-1″]

Home

Lastest Impetigo News

Published by:

Leave it up to medical science to spoil a kiss
Meanwhile, those aforementioned 80 million different kinds of bacteria include pneumococcus, which can cause pneumonia; Group A streptococcus, a bacterium that can cause strep throat, the skin disease impetigo and occasionally even life-threatening …
Read more on NorthJersey.com

Doctor testifies as first witness in infant injury trial
Regarding the scrotum injuries, Klammer said one doctor diagnosed the blemish as impetigo, a highly contagious skin infection common among infants and children. Grad's case took six years to reach trial because of changes of plea, a judge recusal, …
Read more on Medina County Gazette

Home

Lastest Chronic Skin Problems News

Published by:

Dilemma over deductibles: Costs crippling middle class
Physician Praveen Arla is witnessing a reversal of health care fortunes: Poor, long-uninsured patients are getting Medicaid through Obamacare and finally coming to his office for care. But middle-class workers are increasingly staying away. "It's flip …
Read more on USA TODAY

The Healing Warmth of Moxibustion
Today moxa is used to treat a wide range of issues, such as chronic digestive disturbance, menstrual problems, reproductive concerns, and advanced illnesses such as tuberculosis, Lyme disease, and cancer. “It's very powerful for pain,” said Stuardi …
Read more on The Epoch Times

Home

Lastest Paronychia News

Published by:

Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q3 2014 Results – Earnings …
Inhibition of wild-type EGFR is associated with cutaneous toxicities such as rash, stomatitis and paronychia, all of which may significantly impact patients' quality of life, can result in treatment discontinuation and can cause patient distress. We …
Read more on Seeking Alpha (registration)

Boehringer Ingelheim and CureVac announce collaboration to develop next …
… common adverse reactions in the pivotal study (greater than or equal to 20% all grades & vs pemetrexed/cisplatin-treated patients (n=111)) were diarrhea (96% vs 23%), rash/dermatitis acneiform (90% vs 11%), stomatitis (71% vs 15%), paronychia (58 …
Read more on MarketWatch

Home

Lastest Dermatitis Research News

Published by:

ARIA Widens Sales Turf, NRX Skips A Beat, NDRM Triples On Parkinson''s Study
The trial, dubbed KINSHIP, designed to enroll about 50 adult patients with mild to moderate atopic dermatitis is being conducted at clinical research centers in Canada. AQXP closed Tuesday's trading 6.46% higher at $ 7.25.
Read more on Nasdaq

Aquinox Pharma begins dosing in phase 2 trial of AQX-1125 in atopic dermatitis
The KINSHIP clinical trial is being conducted at clinical research centers in Canada as a randomized, double-blind, multicenter, placebo-controlled phase 2 trial evaluating the efficacy and safety of AQX-1125 in approximately 50 adult patients with …
Read more on pharmabiz.com

Moisturizer Reduces Eczema in High-Risk Newborns
The researchers conclude that applying a moisturizer from birth is "a feasible, safe, and effective approach" for the prevention of atopic dermatitis. If the benefit is confirmed in larger trials, this simple low-cost intervention could reduce the …
Read more on Medscape

Home

Lastest Acne Scars auctions

Published by:

acne scars eBay auctions you should keep an eye on:

[wprebay kw=”acne+scars” num=”14″ ebcat=”-1″]
[wprebay kw=”acne+scars” num=”15″ ebcat=”-1″]
[wprebay kw=”acne+scars” num=”16″ ebcat=”-1″]

Home

Lastest Paronychia News

Published by:

Interim Data from Rociletinib (CO-1686) Phase 1/2 Study Shows Compelling and …
Inhibition of wild-type EGFR is associated with cutaneous (and other) toxicities such as acneiform rash, stomatitis and paronychia, all of which may significantly impact patients' quality of life and result in treatment discontinuation and patient …
Read more on FierceBiotech

New drug shows promise against treatment-resistant non-small cell lung cancer
Current TKIs inhibit the normal EGFR as well as the mutant EGFR, causing acne-like skin rashes and paronychia – an inflammation of the folds of tissue around finger and toe nails – both of which can be very troublesome for patients." Patients with …
Read more on News-Medical.net

Clovis Oncology's (CLVS) CEO Presents at Credit Suisse 2014 Healthcare …
Hi, good afternoon. My name is Ravi Mehrotra. I'm the Senior Biotechnology Analyst for Credit Suisse. It gives me great pleasure to introduce to you Pat Mahaffy, CEO of Clovis. I'm actually going to break them all to: A, we're going to do a little bit …
Read more on Seeking Alpha (registration)